Literature DB >> 33351785

TCF-1 regulates HIV-specific CD8+ T cell expansion capacity.

Rachel L Rutishauser1, Christian Deo T Deguit1,2, Joseph Hiatt3,4,5, Franziska Blaeschke3,6,7, Theodore L Roth3,4,5, Lynn Wang1, Kyle A Raymond8,9, Carly E Starke10, Joseph C Mudd10, Wenxuan Chen1, Carolyn Smullin1, Rodrigo Matus-Nicodemos11, Rebecca Hoh1, Melissa Krone12, Frederick M Hecht1, Christopher D Pilcher1, Jeffrey N Martin12, Richard A Koup13, Daniel C Douek11, Jason M Brenchley10, Rafick-Pierre Sékaly14, Satish K Pillai8,9, Alexander Marson1,3,6,7,15,16,17, Steven G Deeks1, Joseph M McCune1, Peter W Hunt1.   

Abstract

Although many HIV cure strategies seek to expand HIV-specific CD8+ T cells to control the virus, all are likely to fail if cellular exhaustion is not prevented. A loss in stem-like memory properties (i.e., the ability to proliferate and generate secondary effector cells) is a key feature of exhaustion; little is known, however, about how these properties are regulated in human virus-specific CD8+ T cells. We found that virus-specific CD8+ T cells from humans and nonhuman primates naturally controlling HIV/SIV infection express more of the transcription factor TCF-1 than noncontrollers. HIV-specific CD8+ T cell TCF-1 expression correlated with memory marker expression and expansion capacity and declined with antigenic stimulation. CRISPR-Cas9 editing of TCF-1 in human primary T cells demonstrated a direct role in regulating expansion capacity. Collectively, these data suggest that TCF-1 contributes to the regulation of the stem-like memory property of secondary expansion capacity of HIV-specific CD8+ T cells, and they provide a rationale for exploring the enhancement of this pathway in T cell-based therapeutic strategies for HIV.

Entities:  

Keywords:  AIDS/HIV; Adaptive immunity; Immunology; T cells

Mesh:

Substances:

Year:  2021        PMID: 33351785      PMCID: PMC7934879          DOI: 10.1172/jci.insight.136648

Source DB:  PubMed          Journal:  JCI Insight        ISSN: 2379-3708


  87 in total

1.  Cutting Edge: IL-12 inversely regulates T-bet and eomesodermin expression during pathogen-induced CD8+ T cell differentiation.

Authors:  Naofumi Takemoto; Andrew M Intlekofer; John T Northrup; E John Wherry; Steven L Reiner
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

2.  TCF1 expression marks self-renewing human CD8+ T cells.

Authors:  Radomir Kratchmarov; Arthur M Magun; Steven L Reiner
Journal:  Blood Adv       Date:  2018-07-24

3.  Cutting edge: generation of memory precursors and functional memory CD8+ T cells depends on T cell factor-1 and lymphoid enhancer-binding factor-1.

Authors:  Xinyuan Zhou; Hai-Hui Xue
Journal:  J Immunol       Date:  2012-08-08       Impact factor: 5.422

4.  Dysfunctional HIV-specific CD8+ T cell proliferation is associated with increased caspase-8 activity and mediated by necroptosis.

Authors:  Gaurav D Gaiha; Kevin J McKim; Matthew Woods; Thomas Pertel; Janine Rohrbach; Natasha Barteneva; Christopher R Chin; Dongfang Liu; Damien Z Soghoian; Kevin Cesa; Shannon Wilton; Michael T Waring; Adam Chicoine; Travis Doering; E John Wherry; Daniel E Kaufmann; Mathias Lichterfeld; Abraham L Brass; Bruce D Walker
Journal:  Immunity       Date:  2014-12-08       Impact factor: 31.745

5.  Differential Impact of In Vivo CD8+ T Lymphocyte Depletion in Controller versus Progressor Simian Immunodeficiency Virus-Infected Macaques.

Authors:  Ankita Chowdhury; Timothy L Hayes; Steven E Bosinger; Benton O Lawson; Thomas Vanderford; Joern E Schmitz; Mirko Paiardini; Michael Betts; Ann Chahroudi; Jacob D Estes; Guido Silvestri
Journal:  J Virol       Date:  2015-06-10       Impact factor: 5.103

6.  Association Between Single-Nucleotide Polymorphisms in HLA Alleles and Human Immunodeficiency Virus Type 1 Viral Load in Demographically Diverse, Antiretroviral Therapy-Naive Participants From the Strategic Timing of AntiRetroviral Treatment Trial.

Authors:  Christina Ekenberg; Man-Hung Tang; Adrian G Zucco; Daniel D Murray; Cameron Ross MacPherson; Xiaojun Hu; Brad T Sherman; Marcelo H Losso; Robin Wood; Roger Paredes; Jean-Michel Molina; Marie Helleberg; Nureen Jina; Cissy M Kityo; Eric Florence; Mark N Polizzotto; James D Neaton; H Clifford Lane; Jens D Lundgren
Journal:  J Infect Dis       Date:  2019-09-13       Impact factor: 5.226

7.  T cell factor-1 and β-catenin control the development of memory-like CD8 thymocytes.

Authors:  Archna Sharma; Qinghua Chen; Trang Nguyen; Qing Yu; Jyoti Misra Sen
Journal:  J Immunol       Date:  2012-04-15       Impact factor: 5.422

8.  Peripheral T Follicular Helper Cells Are the Major HIV Reservoir within Central Memory CD4 T Cells in Peripheral Blood from Chronically HIV-Infected Individuals on Combination Antiretroviral Therapy.

Authors:  Suresh Pallikkuth; Mark Sharkey; Dunja Z Babic; Sachin Gupta; Geoffrey W Stone; Margaret A Fischl; Mario Stevenson; Savita Pahwa
Journal:  J Virol       Date:  2015-12-16       Impact factor: 5.103

9.  CD160-associated CD8 T-cell functional impairment is independent of PD-1 expression.

Authors:  Selena Viganò; Riddhima Banga; Florence Bellanger; Céline Pellaton; Alex Farina; Denis Comte; Alexandre Harari; Matthieu Perreau
Journal:  PLoS Pathog       Date:  2014-09-25       Impact factor: 6.823

10.  HIV-Specific CD8+ T Cells Exhibit Reduced and Differentially Regulated Cytolytic Activity in Lymphoid Tissue.

Authors:  Morgan A Reuter; Perla M Del Rio Estrada; Marcus Buggert; Constantinos Petrovas; Sara Ferrando-Martinez; Son Nguyen; Alberto Sada Japp; Yuria Ablanedo-Terrazas; Amaranta Rivero-Arrieta; Leticia Kuri-Cervantes; Heidi M Gunzelman; Emma Gostick; David A Price; Richard A Koup; Ali Naji; David H Canaday; Gustavo Reyes-Terán; Michael R Betts
Journal:  Cell Rep       Date:  2017-12-19       Impact factor: 9.423

View more
  16 in total

1.  CXCL10 chemokine regulates heterogeneity of the CD8+ T cell response and viral set point during chronic infection.

Authors:  Aleksandra J Ozga; Melvyn T Chow; Mateus E Lopes; Rachel L Servis; Mauro Di Pilato; Philippe Dehio; Jeffrey Lian; Thorsten R Mempel; Andrew D Luster
Journal:  Immunity       Date:  2021-11-29       Impact factor: 31.745

2.  Functional impairment of HIV-specific CD8+ T cells precedes aborted spontaneous control of viremia.

Authors:  David R Collins; Jonathan M Urbach; Zachary J Racenet; Umar Arshad; Karen A Power; Ruchi M Newman; Geetha H Mylvaganam; Ngoc L Ly; Xiaodong Lian; Anna Rull; Yelizaveta Rassadkina; Adrienne G Yanez; Michael J Peluso; Steven G Deeks; Francesc Vidal; Mathias Lichterfeld; Xu G Yu; Gaurav D Gaiha; Todd M Allen; Bruce D Walker
Journal:  Immunity       Date:  2021-09-07       Impact factor: 43.474

3.  Downregulation of TCF1 in HIV Infection Impairs T-cell Proliferative Capacity by Disrupting Mitochondrial Function.

Authors:  Hong-Jiao Cai; Jue Shi; Lin-Bo Yin; Jie-Fu Zheng; Ya-Jing Fu; Yong-Jun Jiang; Hong Shang; Zi-Ning Zhang
Journal:  Front Microbiol       Date:  2022-07-06       Impact factor: 6.064

Review 4.  A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.

Authors:  Samaa T Gobran; Petronela Ancuta; Naglaa H Shoukry
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

Review 5.  Role of CD4+ T Cells in the Control of Viral Infections: Recent Advances and Open Questions.

Authors:  Jérôme Kervevan; Lisa A Chakrabarti
Journal:  Int J Mol Sci       Date:  2021-01-07       Impact factor: 5.923

6.  Role of Circulating T Follicular Helper Cells and Stem-Like Memory CD4+ T Cells in the Pathogenesis of HIV-2 Infection and Disease Progression.

Authors:  Sivasankaran Munusamy Ponnan; K K Vidyavijayan; Kannan Thiruvengadam; Nancy Hilda J; Manikannan Mathayan; Kailapuri Gangatharan Murugavel; Luke Elizabeth Hanna
Journal:  Front Immunol       Date:  2021-04-16       Impact factor: 7.561

Review 7.  Immune checkpoint blockade in HIV.

Authors:  Celine Gubser; Chris Chiu; Sharon R Lewin; Thomas A Rasmussen
Journal:  EBioMedicine       Date:  2022-02-02       Impact factor: 8.143

Review 8.  How elite controllers and posttreatment controllers inform our search for an HIV-1 cure.

Authors:  Jonathan Z Li; Joel N Blankson
Journal:  J Clin Invest       Date:  2021-06-01       Impact factor: 19.456

9.  Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19.

Authors:  Ran Jia; Xiangshi Wang; Pengcheng Liu; Xiaozhen Liang; Yanling Ge; He Tian; Hailing Chang; Hao Zhou; Mei Zeng; Jin Xu
Journal:  Virol Sin       Date:  2020-07-22       Impact factor: 4.327

Review 10.  Human hepatitis D virus-specific T cell epitopes.

Authors:  Matin Kohsar; Johanna Landahl; Christoph Neumann-Haefelin; Julian Schulze Zur Wiesch
Journal:  JHEP Rep       Date:  2021-04-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.